Last 12 months
Inside the activity.
2 purchase rows · 107 sale rows
Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.Monthly counts
| Month | Purchases | Sales |
|---|---|---|
| Nov 2025 | 0 | 11 |
| Dec 2025 | 0 | 5 |
| Jan 2026 | 0 | 1 |
| Feb 2026 | 0 | 1 |
| Mar 2026 | 2 | 3 |
| Apr 2026 | 0 | 1 |
| May 2026 | 0 | 5 |
| Jun 2026 | 0 | 12 |
| Jul 2026 | 0 | 26 |
| Aug 2026 | 0 | 18 |
| Sep 2026 | 0 | 15 |
| Oct 2026 | 0 | 9 |
Latest available
Insider transactions
Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Owner / reported role | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| February 11, 2025 Filed Feb 14, 2025 01:20 UTC |
Hunt HazelChief Scientific Officer
|
Exercise / conversionCommon Stock | 150,000 | $3.29 | $493,500.00 |
DisclosureSEC source: 0000950170-25-020219 · ownership.xml · nonDerivative · entry 1 Hunt Hazel · CIK 0001698307 · Chief Scientific Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 268,581 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| February 10, 2025 Filed Feb 13, 2025 01:26 UTC |
Swisher Daniel N JRDirector
|
Exercise / conversionStock option (right to buy) · Derivative | 2,200 | $0.00 Strike: $12.13 | $0.00 |
DisclosureSEC source: 0000950170-25-019214 · ownership.xml · derivative · entry 3 Swisher Daniel N JR · CIK 0001323113 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 6,200 Underlying: Common Stock · 2,200 shares Expires 2027-05-24 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: Fully exercisable. Read SEC document |
| February 10, 2025 Filed Feb 13, 2025 01:26 UTC |
Swisher Daniel N JRDirector
|
SaleCommon Stock | 2,200 | $68.08 | $149,776.00 |
DisclosureSEC source: 0000950170-25-019214 · ownership.xml · nonDerivative · entry 2 Swisher Daniel N JR · CIK 0001323113 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 0 F1 · kind: The transaction was made pursuant to a 10b5-1 plan in effect at the time of this transaction. Read SEC document |
| February 10, 2025 Filed Feb 13, 2025 01:26 UTC |
Swisher Daniel N JRDirector
|
Exercise / conversionCommon Stock | 2,200 | $12.13 | $26,686.00 |
DisclosureSEC source: 0000950170-25-019214 · ownership.xml · nonDerivative · entry 1 Swisher Daniel N JR · CIK 0001323113 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 2,200 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| February 03, 2025 Filed Feb 5, 2025 21:07 UTC |
Maduck SeanSee Remarks
|
Exercise / conversionStock option (right to buy) · Derivative | 8,014 | $0.00 Strike: $5.05 | $0.00 |
DisclosureSEC source: 0000950170-25-014463 · ownership.xml · derivative · entry 7 Maduck Sean · CIK 0001698310 · See Remarks 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 141,986 Underlying: Common Stock · 8,014 shares Expires 2026-05-02 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F5 · derivative.exercise_date: Fully exercisable. Read SEC document |
| February 03, 2025 Filed Feb 5, 2025 21:07 UTC |
Maduck SeanSee Remarks
|
Exercise / conversionStock option (right to buy) · Derivative | 11,986 | $0.00 Strike: $3.88 | $0.00 |
DisclosureSEC source: 0000950170-25-014463 · ownership.xml · derivative · entry 6 Maduck Sean · CIK 0001698310 · See Remarks 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 10,000 Underlying: Common Stock · 11,986 shares Expires 2026-02-26 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F5 · derivative.exercise_date: Fully exercisable. Read SEC document |
| February 03, 2025 Filed Feb 5, 2025 21:07 UTC |
Maduck SeanSee Remarks
|
SaleCommon Stock | 20,000 | $66.92 | $1,338,400.00 |
DisclosureSEC source: 0000950170-25-014463 · ownership.xml · nonDerivative · entry 3 Maduck Sean · CIK 0001698310 · See Remarks 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 85,318 F2 · kind: The transaction was made pursuant to a 10b5-1 plan in effect at the time of this transaction. F1 · balance_after: Includes 636 shares underlying unvested restricted stock awards granted to the Reporting Person by the Issuer on March 1, 2024, 458 shares underlying unvested restricted stock awards granted to the Reporting Person by the Issuer on September 3, 2024 and 265 shares underlying unvested restricted stock awards granted to the Reporting Person by the Issuer on December 2, 2024. 100% of the shares underlying the restricted stock awards will vest on the one-year anniversary of the grant date provided the Reporting Person satisfies certain requirements. Read SEC document |
| February 03, 2025 Filed Feb 5, 2025 21:07 UTC |
Maduck SeanSee Remarks
|
Exercise / conversionCommon Stock | 8,014 | $5.05 | $40,470.70 |
DisclosureSEC source: 0000950170-25-014463 · ownership.xml · nonDerivative · entry 2 Maduck Sean · CIK 0001698310 · See Remarks 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 105,318 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · balance_after: Includes 636 shares underlying unvested restricted stock awards granted to the Reporting Person by the Issuer on March 1, 2024, 458 shares underlying unvested restricted stock awards granted to the Reporting Person by the Issuer on September 3, 2024 and 265 shares underlying unvested restricted stock awards granted to the Reporting Person by the Issuer on December 2, 2024. 100% of the shares underlying the restricted stock awards will vest on the one-year anniversary of the grant date provided the Reporting Person satisfies certain requirements. Read SEC document |
| February 03, 2025 Filed Feb 5, 2025 21:07 UTC |
Maduck SeanSee Remarks
|
Exercise / conversionCommon Stock | 11,986 | $3.88 | $46,505.68 |
DisclosureSEC source: 0000950170-25-014463 · ownership.xml · nonDerivative · entry 1 Maduck Sean · CIK 0001698310 · See Remarks 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 97,304 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · balance_after: Includes 636 shares underlying unvested restricted stock awards granted to the Reporting Person by the Issuer on March 1, 2024, 458 shares underlying unvested restricted stock awards granted to the Reporting Person by the Issuer on September 3, 2024 and 265 shares underlying unvested restricted stock awards granted to the Reporting Person by the Issuer on December 2, 2024. 100% of the shares underlying the restricted stock awards will vest on the one-year anniversary of the grant date provided the Reporting Person satisfies certain requirements. Read SEC document |
| February 03, 2025 Filed Feb 5, 2025 21:05 UTC |
Lyon Joseph DouglasSee Remarks
|
Exercise / conversionStock option (right to buy) · Derivative | 3,429 | $0.00 Strike: $13.56 | $0.00 |
DisclosureSEC source: 0000950170-25-014454 · ownership.xml · derivative · entry 5 Lyon Joseph Douglas · CIK 0001817838 · See Remarks 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 96,571 Underlying: Common Stock · 3,429 shares Expires 2030-02-07 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_date: Fully exercisable. Read SEC document |
| February 03, 2025 Filed Feb 5, 2025 21:05 UTC |
Lyon Joseph DouglasSee Remarks
|
Exercise / conversionStock option (right to buy) · Derivative | 1,571 | $0.00 Strike: $11.35 | $0.00 |
DisclosureSEC source: 0000950170-25-014454 · ownership.xml · derivative · entry 4 Lyon Joseph Douglas · CIK 0001817838 · See Remarks 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 2,596 Underlying: Common Stock · 1,571 shares Expires 2029-02-08 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_date: Fully exercisable. Read SEC document |
| February 03, 2025 Filed Feb 5, 2025 21:05 UTC |
Lyon Joseph DouglasSee Remarks
|
SaleCommon Stock | 5,000 | $66.92 | $334,600.00 |
DisclosureSEC source: 0000950170-25-014454 · ownership.xml · nonDerivative · entry 3 Lyon Joseph Douglas · CIK 0001817838 · See Remarks 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 8,759 F2 · kind: The transaction was made pursuant to a 10b5-1 plan in effect at the time of this transaction. F1 · balance_after: Includes 507 shares underlying unvested restricted stock awards granted to the Reporting Person by the Issuer on March 1, 2024, 1,232 shares underlying unvested restricted stock awards granted to the Reporting Person by the Issuer on June 3, 2024, 372 shares underlying unvested restricted stock awards granted to the Reporting Person by the Issuer on September 3, 2024 and 215 shares underlying unvested restricted stock awards granted to the Reporting Person by the Issuer on December 2, 2024. 100% of the shares underlying the restricted stock awards will vest on the one-year anniversary of the grant date provided the Reporting Person satisfies certain requirements. Read SEC document |
| February 03, 2025 Filed Feb 5, 2025 21:05 UTC |
Lyon Joseph DouglasSee Remarks
|
Exercise / conversionCommon Stock | 3,429 | $13.56 | $46,497.24 |
DisclosureSEC source: 0000950170-25-014454 · ownership.xml · nonDerivative · entry 2 Lyon Joseph Douglas · CIK 0001817838 · See Remarks 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 13,759 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · balance_after: Includes 507 shares underlying unvested restricted stock awards granted to the Reporting Person by the Issuer on March 1, 2024, 1,232 shares underlying unvested restricted stock awards granted to the Reporting Person by the Issuer on June 3, 2024, 372 shares underlying unvested restricted stock awards granted to the Reporting Person by the Issuer on September 3, 2024 and 215 shares underlying unvested restricted stock awards granted to the Reporting Person by the Issuer on December 2, 2024. 100% of the shares underlying the restricted stock awards will vest on the one-year anniversary of the grant date provided the Reporting Person satisfies certain requirements. Read SEC document |
| February 03, 2025 Filed Feb 5, 2025 21:05 UTC |
Lyon Joseph DouglasSee Remarks
|
Exercise / conversionCommon Stock | 1,571 | $11.35 | $17,830.85 |
DisclosureSEC source: 0000950170-25-014454 · ownership.xml · nonDerivative · entry 1 Lyon Joseph Douglas · CIK 0001817838 · See Remarks 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 10,330 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · balance_after: Includes 507 shares underlying unvested restricted stock awards granted to the Reporting Person by the Issuer on March 1, 2024, 1,232 shares underlying unvested restricted stock awards granted to the Reporting Person by the Issuer on June 3, 2024, 372 shares underlying unvested restricted stock awards granted to the Reporting Person by the Issuer on September 3, 2024 and 215 shares underlying unvested restricted stock awards granted to the Reporting Person by the Issuer on December 2, 2024. 100% of the shares underlying the restricted stock awards will vest on the one-year anniversary of the grant date provided the Reporting Person satisfies certain requirements. Read SEC document |
| January 27, 2025 Filed Jan 29, 2025 21:14 UTC |
WILSON JAMES NDirector
|
GiftCommon Stock | 7,800 | $0.00 | $0.00 |
DisclosureSEC source: 0000950170-25-010499 · ownership.xml · nonDerivative · entry 1 WILSON JAMES N · CIK 0001236387 · Director 10b5-1 filing: No plan indicated Ownership: Indirect · James N. Wilson and Pamela D. Wilson Trust Disclosed balance after: 1,445,168 F1 · ownership.nature: Reporting Person has voting power over the shares held by the James N. Wilson and Pamela D. Wilson Trust and James and Pamela Wilson Family Partners pursuant to voting agreements and disclaims beneficial ownership of all of such shares, except to the extent of his pecuniary interest therein. Read SEC document |
| January 27, 2025 Filed Apr 23, 2025 23:41 UTC |
Robb Gary CharlesChief Business Officer
|
GiftCommon Stock | 313 | $0.00 | $0.00 |
DisclosureSEC source: 0000950170-25-057620 · ownership.xml · nonDerivative · entry 2 Robb Gary Charles · CIK 0001529655 · Chief Business Officer 10b5-1 filing: No plan indicated Ownership: Indirect · Custodial Account for Child Disclosed balance after: 11,211 F1 · ownership.nature: These shares are held by a child of the Reporting Person through a custodial account under the Uniform Transfers to Minors Act for which the Reporting Person is custodian. Read SEC document |
| January 27, 2025 Filed Apr 23, 2025 23:41 UTC |
Robb Gary CharlesChief Business Officer
|
GiftCommon Stock | 313 | $0.00 | $0.00 |
DisclosureSEC source: 0000950170-25-057620 · ownership.xml · nonDerivative · entry 1 Robb Gary Charles · CIK 0001529655 · Chief Business Officer 10b5-1 filing: No plan indicated Ownership: Indirect · Custodial Account for Child Disclosed balance after: 11,211 F1 · ownership.nature: These shares are held by a child of the Reporting Person through a custodial account under the Uniform Transfers to Minors Act for which the Reporting Person is custodian. Read SEC document |
| January 22, 2025 Filed Jan 25, 2025 01:20 UTC |
WILSON JAMES NDirector
|
Exercise / conversionStock option (right to buy) · Derivative | 250,000 | $0.00 Strike: $3.29 | $0.00 |
DisclosureSEC source: 0000950170-25-008963 · ownership.xml · derivative · entry 6 WILSON JAMES N · CIK 0001236387 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 250,000 shares Expires 2025-02-18 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · derivative.exercise_date: Fully exercisable. Read SEC document |
| January 22, 2025 Filed Jan 25, 2025 01:20 UTC |
WILSON JAMES NDirector
|
OtherCommon Stock | 146,742 | $0.00 | $0.00 |
DisclosureSEC source: 0000950170-25-008963 · ownership.xml · nonDerivative · entry 4 WILSON JAMES N · CIK 0001236387 · Director 10b5-1 filing: No plan indicated Ownership: Indirect · James N. Wilson and Pamela D. Wilson Trust Disclosed balance after: 1,452,968 F2 · kind: Transfer of shares without consideration to the James N. Wilson and Pamela D. Wilson Trust. F3 · ownership.nature: Reporting Person has voting power over the shares held by the James N. Wilson and Pamela D. Wilson Trust and James and Pamela Wilson Family Partners pursuant to voting agreements and disclaims beneficial ownership of all of such shares, except to the extent of his pecuniary interest therein. Read SEC document |
| January 22, 2025 Filed Jan 25, 2025 01:20 UTC |
WILSON JAMES NDirector
|
GiftCommon Stock | 146,742 | $0.00 | $0.00 |
DisclosureSEC source: 0000950170-25-008963 · ownership.xml · nonDerivative · entry 3 WILSON JAMES N · CIK 0001236387 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Read SEC document |
| January 22, 2025 Filed Jan 25, 2025 01:20 UTC |
WILSON JAMES NDirector
|
Tax withholdingCommon Stock | 103,258 | $59.03 | $6,095,319.74 |
DisclosureSEC source: 0000950170-25-008963 · ownership.xml · nonDerivative · entry 2 WILSON JAMES N · CIK 0001236387 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 146,742 F1 · kind: These shares were withheld so the Reporting Person could satisfy the exercise price and tax liability arising from a net (cashless) exercise of stock options that occurred on January 22, 2025. Read SEC document |
| January 22, 2025 Filed Jan 25, 2025 01:20 UTC |
WILSON JAMES NDirector
|
Exercise / conversionCommon Stock | 250,000 | $3.29 | $822,500.00 |
DisclosureSEC source: 0000950170-25-008963 · ownership.xml · nonDerivative · entry 1 WILSON JAMES N · CIK 0001236387 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 250,000 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| January 10, 2025 Filed Jan 15, 2025 00:30 UTC |
Swisher Daniel N JRDirector
|
Exercise / conversionStock option (right to buy) · Derivative | 2,200 | $0.00 Strike: $12.13 | $0.00 |
DisclosureSEC source: 0000950170-25-005536 · ownership.xml · derivative · entry 3 Swisher Daniel N JR · CIK 0001323113 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 8,400 Underlying: Common Stock · 2,200 shares Expires 2027-05-24 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: Fully exercisable. Read SEC document |
| January 10, 2025 Filed Jan 15, 2025 00:30 UTC |
Swisher Daniel N JRDirector
|
SaleCommon Stock | 2,200 | $50.54 | $111,188.00 |
DisclosureSEC source: 0000950170-25-005536 · ownership.xml · nonDerivative · entry 2 Swisher Daniel N JR · CIK 0001323113 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 0 F1 · kind: The transaction was made pursuant to a 10b5-1 plan in effect at the time of this transaction. Read SEC document |
| January 10, 2025 Filed Jan 15, 2025 00:30 UTC |
Swisher Daniel N JRDirector
|
Exercise / conversionCommon Stock | 2,200 | $12.13 | $26,686.00 |
DisclosureSEC source: 0000950170-25-005536 · ownership.xml · nonDerivative · entry 1 Swisher Daniel N JR · CIK 0001323113 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 2,200 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| January 03, 2025 Filed Jan 7, 2025 00:15 UTC |
Robb Gary CharlesChief Business Officer
|
Exercise / conversionStock option (right to buy) · Derivative | 3,037 | $0.00 Strike: $3.29 | $0.00 |
DisclosureSEC source: 0000950170-25-002439 · ownership.xml · derivative · entry 7 Robb Gary Charles · CIK 0001529655 · Chief Business Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 3,037 shares Expires 2025-02-18 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F5 · derivative.exercise_date: Fully exercisable. Read SEC document |
| January 03, 2025 Filed Jan 7, 2025 00:15 UTC |
Robb Gary CharlesChief Business Officer
|
Exercise / conversionCommon Stock | 3,037 | $3.29 | $9,991.73 |
DisclosureSEC source: 0000950170-25-002439 · ownership.xml · nonDerivative · entry 3 Robb Gary Charles · CIK 0001529655 · Chief Business Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 23,156 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · balance_after: Includes 697 shares underlying unvested restricted stock awards granted to the Reporting Person by the Issuer on March 1, 2024, 1,818 shares underlying unvested restricted stock awards granted to the Reporting Person by the Issuer on June 3, 2024, 503 shares underlying unvested restricted stock awards granted to the Reporting Person by the Issuer on September 3, 2024 and 290 shares underlying unvested restricted stock awards granted to the Reporting Person by the Issuer on December 2, 2024. 100% of the shares underlying the restricted stock awards will vest on the one-year anniversary of the grant date provided the Reporting Person satisfies certain requirements. Read SEC document |
| January 02, 2025 Filed Jan 7, 2025 00:59 UTC |
Maduck SeanSee Remarks
|
Exercise / conversionStock option (right to buy) · Derivative | 20,000 | $0.00 Strike: $3.88 | $0.00 |
DisclosureSEC source: 0000950170-25-002466 · ownership.xml · derivative · entry 5 Maduck Sean · CIK 0001698310 · See Remarks 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 21,986 Underlying: Common Stock · 20,000 shares Expires 2026-02-26 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F5 · derivative.exercise_date: Fully exercisable. Read SEC document |
| January 02, 2025 Filed Jan 7, 2025 00:59 UTC |
Maduck SeanSee Remarks
|
SaleCommon Stock | 20,000 | $50.39 | $1,007,800.00 |
DisclosureSEC source: 0000950170-25-002466 · ownership.xml · nonDerivative · entry 2 Maduck Sean · CIK 0001698310 · See Remarks 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 85,318 F2 · kind: The transaction was made pursuant to a 10b5-1 plan in effect at the time of this transaction. F1 · balance_after: Includes 636 shares underlying unvested restricted stock awards granted to the Reporting Person by the Issuer on March 1, 2024, 458 shares underlying unvested restricted stock awards granted to the Reporting Person by the Issuer on September 3, 2024 and 265 shares underlying unvested restricted stock awards granted to the Reporting Person by the Issuer on December 2, 2024. 100% of the shares underlying the restricted stock awards will vest on the one-year anniversary of the grant date provided the Reporting Person satisfies certain requirements. Read SEC document |
| January 02, 2025 Filed Jan 7, 2025 00:59 UTC |
Maduck SeanSee Remarks
|
Exercise / conversionCommon Stock | 20,000 | $3.88 | $77,600.00 |
DisclosureSEC source: 0000950170-25-002466 · ownership.xml · nonDerivative · entry 1 Maduck Sean · CIK 0001698310 · See Remarks 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 105,318 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · balance_after: Includes 636 shares underlying unvested restricted stock awards granted to the Reporting Person by the Issuer on March 1, 2024, 458 shares underlying unvested restricted stock awards granted to the Reporting Person by the Issuer on September 3, 2024 and 265 shares underlying unvested restricted stock awards granted to the Reporting Person by the Issuer on December 2, 2024. 100% of the shares underlying the restricted stock awards will vest on the one-year anniversary of the grant date provided the Reporting Person satisfies certain requirements. Read SEC document |
| January 02, 2025 Filed Jan 7, 2025 00:24 UTC |
Lyon Joseph DouglasSee Remarks
|
Exercise / conversionStock option (right to buy) · Derivative | 5,000 | $0.00 Strike: $11.35 | $0.00 |
DisclosureSEC source: 0000950170-25-002446 · ownership.xml · derivative · entry 3 Lyon Joseph Douglas · CIK 0001817838 · See Remarks 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 4,167 Underlying: Common Stock · 5,000 shares Expires 2029-02-08 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_date: Fully exercisable. Read SEC document |
| January 02, 2025 Filed Jan 7, 2025 00:24 UTC |
Lyon Joseph DouglasSee Remarks
|
SaleCommon Stock | 5,000 | $50.39 | $251,950.00 |
DisclosureSEC source: 0000950170-25-002446 · ownership.xml · nonDerivative · entry 2 Lyon Joseph Douglas · CIK 0001817838 · See Remarks 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 8,759 F2 · kind: The transaction was made pursuant to a 10b5-1 plan in effect at the time of this transaction. F1 · balance_after: Includes 507 shares underlying unvested restricted stock awards granted to the Reporting Person by the Issuer on March 1, 2024, 1,232 shares underlying unvested restricted stock awards granted to the Reporting Person by the Issuer on June 3, 2024, 372 shares underlying unvested restricted stock awards granted to the Reporting Person by the Issuer on September 3, 2024 and 215 shares underlying unvested restricted stock awards granted to the Reporting Person by the Issuer on December 2, 2024. 100% of the shares underlying the restricted stock awards will vest on the one-year anniversary of the grant date provided the Reporting Person satisfies certain requirements. Read SEC document |
| January 02, 2025 Filed Jan 7, 2025 00:24 UTC |
Lyon Joseph DouglasSee Remarks
|
Exercise / conversionCommon Stock | 5,000 | $11.35 | $56,750.00 |
DisclosureSEC source: 0000950170-25-002446 · ownership.xml · nonDerivative · entry 1 Lyon Joseph Douglas · CIK 0001817838 · See Remarks 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 13,759 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · balance_after: Includes 507 shares underlying unvested restricted stock awards granted to the Reporting Person by the Issuer on March 1, 2024, 1,232 shares underlying unvested restricted stock awards granted to the Reporting Person by the Issuer on June 3, 2024, 372 shares underlying unvested restricted stock awards granted to the Reporting Person by the Issuer on September 3, 2024 and 215 shares underlying unvested restricted stock awards granted to the Reporting Person by the Issuer on December 2, 2024. 100% of the shares underlying the restricted stock awards will vest on the one-year anniversary of the grant date provided the Reporting Person satisfies certain requirements. Read SEC document |
| January 02, 2025 Filed Jan 7, 2025 00:15 UTC |
Robb Gary CharlesChief Business Officer
|
Exercise / conversionStock option (right to buy) · Derivative | 11,000 | $0.00 Strike: $3.29 | $0.00 |
DisclosureSEC source: 0000950170-25-002439 · ownership.xml · derivative · entry 6 Robb Gary Charles · CIK 0001529655 · Chief Business Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 3,037 Underlying: Common Stock · 11,000 shares Expires 2025-02-18 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F5 · derivative.exercise_date: Fully exercisable. Read SEC document |
| January 02, 2025 Filed Jan 7, 2025 00:15 UTC |
Robb Gary CharlesChief Business Officer
|
SaleCommon Stock | 11,000 | $50.50 | $555,551.70 |
DisclosureSEC source: 0000950170-25-002439 · ownership.xml · nonDerivative · entry 2 Robb Gary Charles · CIK 0001529655 · Chief Business Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 20,119 F2 · kind: This transaction was made pursuant to a 10b5-1 plan in effect at the time of this transaction. F3 · price: Represents the weighted average sale price for the entire number of shares sold. The actual sale prices range from $50.39 to $50.84 per share. Information on the exact number of shares sold at each sale price can be obtained from the issuer upon request. F1 · balance_after: Includes 697 shares underlying unvested restricted stock awards granted to the Reporting Person by the Issuer on March 1, 2024, 1,818 shares underlying unvested restricted stock awards granted to the Reporting Person by the Issuer on June 3, 2024, 503 shares underlying unvested restricted stock awards granted to the Reporting Person by the Issuer on September 3, 2024 and 290 shares underlying unvested restricted stock awards granted to the Reporting Person by the Issuer on December 2, 2024. 100% of the shares underlying the restricted stock awards will vest on the one-year anniversary of the grant date provided the Reporting Person satisfies certain requirements. Read SEC document |
| January 02, 2025 Filed Jan 7, 2025 00:15 UTC |
Robb Gary CharlesChief Business Officer
|
Exercise / conversionCommon Stock | 11,000 | $3.29 | $36,190.00 |
DisclosureSEC source: 0000950170-25-002439 · ownership.xml · nonDerivative · entry 1 Robb Gary Charles · CIK 0001529655 · Chief Business Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 31,119 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · balance_after: Includes 697 shares underlying unvested restricted stock awards granted to the Reporting Person by the Issuer on March 1, 2024, 1,818 shares underlying unvested restricted stock awards granted to the Reporting Person by the Issuer on June 3, 2024, 503 shares underlying unvested restricted stock awards granted to the Reporting Person by the Issuer on September 3, 2024 and 290 shares underlying unvested restricted stock awards granted to the Reporting Person by the Issuer on December 2, 2024. 100% of the shares underlying the restricted stock awards will vest on the one-year anniversary of the grant date provided the Reporting Person satisfies certain requirements. Read SEC document |
| January 01, 2025 Filed Jan 2, 2025 23:03 UTC |
BAKER G LEONARD JRDirector
|
GiftCommon Stock | 0 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-25-000061 · doc4.xml · nonDerivative · entry 1 BAKER G LEONARD JR · CIK 0001201715 · Director 10b5-1 filing: No plan indicated Ownership: Indirect · By Ltd Partnership Disclosed balance after: 3,308,303 F1 · kind: Represents gift of limited partnership interests in a limited partnership to other limited partners. The reporting person disclaims beneficial ownership of the shares held by the limited partnership except as to the reporting person's pecuniary interest therein. F2 · ownership.nature: Shares held by a limited partnership of which the reporting person is a trustee of a trust which is the general partner. The reporting person disclaims beneficial ownership in these shares except as to the reporting person's pecuniary interest therein. Read SEC document |
| December 27, 2024 Filed Dec 31, 2024 21:41 UTC |
WILSON JAMES NDirector
|
GiftCommon Stock | 7,800 | $0.00 | $0.00 |
DisclosureSEC source: 0000950170-24-141638 · ownership.xml · nonDerivative · entry 1 WILSON JAMES N · CIK 0001236387 · Director 10b5-1 filing: No plan indicated Ownership: Indirect · James N. Wilson and Pamela D. Wilson Trust Disclosed balance after: 1,306,226 F1 · ownership.nature: Reporting Person has voting power over the shares held by the James N. Wilson and Pamela D. Wilson Trust and James and Pamela Wilson Family Partners pursuant to voting agreements and disclaims beneficial ownership of all of such shares, except to the extent of his pecuniary interest therein. Read SEC document |
| December 10, 2024 Filed Dec 12, 2024 21:59 UTC |
Swisher Daniel N JRDirector
|
Exercise / conversionStock option (right to buy) · Derivative | 2,200 | $0.00 Strike: $12.13 | $0.00 |
DisclosureSEC source: 0000950170-24-135868 · ownership.xml · derivative · entry 3 Swisher Daniel N JR · CIK 0001323113 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 10,600 Underlying: Common Stock · 2,200 shares Expires 2027-05-24 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: Fully exercisable. Read SEC document |
| December 10, 2024 Filed Dec 12, 2024 21:59 UTC |
Swisher Daniel N JRDirector
|
SaleCommon Stock | 2,200 | $59.46 | $130,812.00 |
DisclosureSEC source: 0000950170-24-135868 · ownership.xml · nonDerivative · entry 2 Swisher Daniel N JR · CIK 0001323113 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 0 F1 · kind: The transaction was made pursuant to a 10b5-1 plan in effect at the time of this transaction. Read SEC document |
| December 10, 2024 Filed Dec 12, 2024 21:59 UTC |
Swisher Daniel N JRDirector
|
Exercise / conversionCommon Stock | 2,200 | $12.13 | $26,686.00 |
DisclosureSEC source: 0000950170-24-135868 · ownership.xml · nonDerivative · entry 1 Swisher Daniel N JR · CIK 0001323113 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 2,200 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| December 02, 2024 Filed Dec 5, 2024 01:02 UTC |
Guyer WilliamChief Development Officer
|
Tax withholdingCommon Stock | 309 | $57.68 | $17,823.12 |
DisclosureSEC source: 0000950170-24-133448 · ownership.xml · nonDerivative · entry 1 Guyer William · CIK 0001879013 · Chief Development Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 5,487 F1 · kind: These shares were withheld by the Issuer in order to satisfy certain tax withholding obligations in connection with the issuance of shares upon the vesting of restricted stock units. F2 · price: The closing price on November 29, 2024 was used to calculate the withholding obligation. Read SEC document |
| December 02, 2024 Filed Dec 5, 2024 00:51 UTC |
Maduck SeanSee Remarks
|
GrantCommon Stock | 265 | $0.00 | $0.00 |
DisclosureSEC source: 0000950170-24-133444 · ownership.xml · nonDerivative · entry 3 Maduck Sean · CIK 0001698310 · See Remarks 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 85,318 F6 · shares: Shares underlie unvested restricted stock awards granted to the Reporting Person by the Issuer under the Purchase Plan. 100% of the shares underlying the restricted stock awards will vest on the one-year anniversary of the grant date provided the Reporting Person remains the beneficial owner of the Purchase Plan Shares through such one-year anniversary. F3 · balance_after: Includes 636 shares underlying unvested restricted stock awards granted to the Reporting Person by the Issuer on March 1, 2024 and 458 shares underlying unvested restricted stock awards granted to the Reporting Person by the Issuer on September 3, 2024. 100% of the shares underlying the restricted stock awards will vest on the one-year anniversary of the grant date provided the Reporting Person satisfies certain requirements. Read SEC document |
| December 02, 2024 Filed Dec 5, 2024 00:51 UTC |
Maduck SeanSee Remarks
|
GrantCommon Stock | 265 | $59.21 | $15,690.65 |
DisclosureSEC source: 0000950170-24-133444 · ownership.xml · nonDerivative · entry 2 Maduck Sean · CIK 0001698310 · See Remarks 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 85,053 F4 · shares: The Reporting Person purchased shares ("Purchase Plan Shares") of the Issuer's common stock pursuant to a purchase plan ("Purchase Plan") established under the Corcept Therapeutics Incorporated 2024 Incentive Award Plan on December 2, 2024. F5 · price: In accordance with the Purchase Plan, the price was established based on the closing price on the day of the purchase. F3 · balance_after: Includes 636 shares underlying unvested restricted stock awards granted to the Reporting Person by the Issuer on March 1, 2024 and 458 shares underlying unvested restricted stock awards granted to the Reporting Person by the Issuer on September 3, 2024. 100% of the shares underlying the restricted stock awards will vest on the one-year anniversary of the grant date provided the Reporting Person satisfies certain requirements. Read SEC document |
| December 02, 2024 Filed Dec 5, 2024 00:51 UTC |
Maduck SeanSee Remarks
|
Tax withholdingCommon Stock | 295 | $57.68 | $17,015.60 |
DisclosureSEC source: 0000950170-24-133444 · ownership.xml · nonDerivative · entry 1 Maduck Sean · CIK 0001698310 · See Remarks 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 84,788 F1 · kind: These shares were withheld by the Issuer in order to satisfy certain tax withholding obligations in connection with the issuance of shares upon the vesting of restricted stock units. F2 · price: The closing price on November 29, 2024 was used to calculate the withholding obligation. F3 · balance_after: Includes 636 shares underlying unvested restricted stock awards granted to the Reporting Person by the Issuer on March 1, 2024 and 458 shares underlying unvested restricted stock awards granted to the Reporting Person by the Issuer on September 3, 2024. 100% of the shares underlying the restricted stock awards will vest on the one-year anniversary of the grant date provided the Reporting Person satisfies certain requirements. Read SEC document |
| December 02, 2024 Filed Dec 5, 2024 00:41 UTC |
Robb Gary CharlesChief Business Officer
|
GrantCommon Stock | 290 | $0.00 | $0.00 |
DisclosureSEC source: 0000950170-24-133440 · ownership.xml · nonDerivative · entry 3 Robb Gary Charles · CIK 0001529655 · Chief Business Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 20,119 F6 · shares: Shares underlie unvested restricted stock awards granted to the Reporting Person by the Issuer under the Purchase Plan. 100% of the shares underlying the restricted stock awards will vest on the one-year anniversary of the grant date provided the Reporting Person remains the beneficial owner of the Purchase Plan Shares through such one-year anniversary. F3 · balance_after: Includes 697 shares underlying unvested restricted stock awards granted to the Reporting Person by the Issuer on March 1, 2024, 1,818 shares underlying unvested restricted stock awards granted to the Reporting Person by the Issuer on June 3, 2024 and 503 shares underlying unvested restricted stock awards granted to the Reporting Person by the Issuer on September 3, 2024. 100% of the shares underlying the restricted stock awards will vest on the one-year anniversary of the grant date provided the Reporting Person satisfies certain requirements. Read SEC document |
| December 02, 2024 Filed Dec 5, 2024 00:41 UTC |
Robb Gary CharlesChief Business Officer
|
GrantCommon Stock | 290 | $59.21 | $17,170.90 |
DisclosureSEC source: 0000950170-24-133440 · ownership.xml · nonDerivative · entry 2 Robb Gary Charles · CIK 0001529655 · Chief Business Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 19,829 F4 · shares: The Reporting Person purchased shares ("Purchase Plan Shares") of the Issuer's common stock pursuant to a purchase plan ("Purchase Plan") established under the Corcept Therapeutics Incorporated 2024 Incentive Award Plan on December 2, 2024. F5 · price: In accordance with the Purchase Plan, the price was established based on the closing price on the day of the purchase. F3 · balance_after: Includes 697 shares underlying unvested restricted stock awards granted to the Reporting Person by the Issuer on March 1, 2024, 1,818 shares underlying unvested restricted stock awards granted to the Reporting Person by the Issuer on June 3, 2024 and 503 shares underlying unvested restricted stock awards granted to the Reporting Person by the Issuer on September 3, 2024. 100% of the shares underlying the restricted stock awards will vest on the one-year anniversary of the grant date provided the Reporting Person satisfies certain requirements. Read SEC document |
| December 02, 2024 Filed Dec 5, 2024 00:41 UTC |
Robb Gary CharlesChief Business Officer
|
Tax withholdingCommon Stock | 324 | $57.68 | $18,688.32 |
DisclosureSEC source: 0000950170-24-133440 · ownership.xml · nonDerivative · entry 1 Robb Gary Charles · CIK 0001529655 · Chief Business Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 19,539 F1 · kind: These shares were withheld by the Issuer in order to satisfy certain withholding obligations in connection with the issuance of share upon the vesting of restricted stock units. F2 · price: The closing price on November 29, 2024 was used to calculate the withholding obligation. F3 · balance_after: Includes 697 shares underlying unvested restricted stock awards granted to the Reporting Person by the Issuer on March 1, 2024, 1,818 shares underlying unvested restricted stock awards granted to the Reporting Person by the Issuer on June 3, 2024 and 503 shares underlying unvested restricted stock awards granted to the Reporting Person by the Issuer on September 3, 2024. 100% of the shares underlying the restricted stock awards will vest on the one-year anniversary of the grant date provided the Reporting Person satisfies certain requirements. Read SEC document |
| December 02, 2024 Filed Dec 5, 2024 00:40 UTC |
Lyon Joseph DouglasSee Remarks
|
GrantCommon Stock | 215 | $0.00 | $0.00 |
DisclosureSEC source: 0000950170-24-133439 · ownership.xml · nonDerivative · entry 3 Lyon Joseph Douglas · CIK 0001817838 · See Remarks 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 8,759 F6 · shares: Shares underlie unvested restricted stock awards granted to the Reporting Person by the Issuer under the Purchase Plan. 100% of the shares underlying the restricted stock awards will vest on the one-year anniversary of the grant date provided the Reporting Person remains the beneficial owner of the Purchase Plan Shares through such one-year anniversary. F3 · balance_after: Includes 507 shares underlying unvested restricted stock awards granted to the Reporting Person by the Issuer on March 1, 2024, 1,232 shares underlying unvested restricted stock awards granted to the Reporting Person by the Issuer on June 3, 2024 and 372 shares underlying unvested restricted stock awards granted to the Reporting Person by the Issuer on September 3, 2024. 100% of the shares underlying the restricted stock awards will vest on the one-year anniversary of the grant date provided the Reporting Person satisfies certain requirements. Read SEC document |
| December 02, 2024 Filed Dec 5, 2024 00:40 UTC |
Lyon Joseph DouglasSee Remarks
|
GrantCommon Stock | 215 | $59.21 | $12,730.15 |
DisclosureSEC source: 0000950170-24-133439 · ownership.xml · nonDerivative · entry 2 Lyon Joseph Douglas · CIK 0001817838 · See Remarks 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 8,544 F4 · shares: The Reporting Person purchased shares ("Purchase Plan Shares") of the Issuer's common stock pursuant to a purchase plan ("Purchase Plan") established under the Corcept Therapeutics Incorporated 2024 Incentive Award Plan on December 2, 2024. F5 · price: In accordance with the Purchase Plan, the price was established based on the closing price on the day of the purchase. F3 · balance_after: Includes 507 shares underlying unvested restricted stock awards granted to the Reporting Person by the Issuer on March 1, 2024, 1,232 shares underlying unvested restricted stock awards granted to the Reporting Person by the Issuer on June 3, 2024 and 372 shares underlying unvested restricted stock awards granted to the Reporting Person by the Issuer on September 3, 2024. 100% of the shares underlying the restricted stock awards will vest on the one-year anniversary of the grant date provided the Reporting Person satisfies certain requirements. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.